SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 789.76 |
| Enterprise Value ($M) | 1,005.61 |
| Book Value ($M) | 280.32 |
| Book Value / Share | 0.44 |
| Price / Book | 2.82 |
| NCAV ($M) | 177.53 |
| NCAV / Share | 0.28 |
| Price / NCAV | 4.45 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.30 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.12 |
| Current Ratio | 5.56 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 490.99 |
| Assets | 593.78 |
| Liabilities | 313.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 76.99 |
| Operating Income | -173.73 |
| Net Income | -174.57 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -218.62 |
| Cash from Investing | -106.00 |
| Cash from Financing | 334.37 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Deep Track Capital, LP | 5.50 | 362.04 | |
| 13G/A | Rtw Investments, Lp | 0.00 | -100.00 | |
| 13G/A | Ra Capital Management, L.p. | 9.99 | 14.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,075,720 | 7,447,022 | 14.44 | |
| 2,774,507 | 11,222,575 | 24.72 | |
| 1,913,298 | 10,375,033 | 18.44 | |
| 3,042,673 | 14,410,813 | 21.11 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FDMT – 4D Molecular Therapeutics, Inc. | FGEN – FibroGen, Inc. |
| GBIO – Generation Bio Co. | GILD – Gilead Sciences, Inc. |
| GLUE – Monte Rosa Therapeutics, Inc. |